retatrutide approval status 2025 fda ema for Weight Loss: What It Is, How It Works & Side Effects Retatrutide vs Ozempic: Clinical Trial

As a peptide, Retatrutide represents a novel approach within the category of GLP-1 receptor agonists, a class of medications commonly used for metabolic conditions

Genetic factors, too, cannot be overlooked

The short answer is that many of our patients lose weight in the first week of taking semaglutide

doi:10.1007/s10549-025-07678-7 Lus C, Dias J, Firmino-Machado J, et al

The boxed warning also mentions the risk of pancreatitis and that the medication is contraindicated in patients with a personal or family history of medullary thyroid carcinoma (MTC) and patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)